Back to results
US 10,239,911 B2Granted
Beta-D-2′-deoxy-2′-alpha-fluoro-2′-beta-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatment
AssigneeAtea Pharmaceuticals, Inc.
InventorsJean-Pierre Sommadossi, Adel Moussa
Life of this patent
Estimating the term…
Abstract
A compound of the structure: or a pharmaceutically acceptable salt or composition thereof for the treatment of a host infected with or exposed to an HCV virus or other disorders more fully described herein.
Claims24
A method for treating hepatitis C in a host in need thereof comprising administering an anti-HCV effective amount of a compound of the formula:
- or a pharmaceutically acceptable salt thereof, optionally in a pharmaceutically acceptable carrier.
A method for treating hepatitis C in a host in need thereof comprising administering an anti-HCV effective amount of a compound of the formula:
- or a pharmaceutically acceptable salt thereof, optionally in a pharmaceutically acceptable carrier.
Dependencies are inferred from the claim text.